HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 405 participants.
Also called NCT01456000
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 405 participants
- Sponsor
- Registry
-
NCT01456000
-
- Other papers using this trial's data
- Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01456000. Randomized; no masking; primary purpose treatment. Start 2012-01 (registry gives no type); primary completion 2014-12 (actual). Results posted on 2016-09-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- HeartLight Ablation in Patients With Paroxysmal Atrial Fibrillation (PAF)
- Acronym
- HeartLight
- Condition
- Paroxysmal Atrial Fibrillation
- Intervention (Device)
- EAS-AC (HeartLight)
- Intervention (Procedure)
- Control Arm Ablation
- Lead sponsor
- CardioFocus
Record details
- Record id
cardio:ct-nct01456000- Content hash
d5c7377017dcbe3eb4164e9a1d55ccb0377d1252c002218e0715a0e980f7f7a8